Amicus Therapeutics, Inc. (FOLD)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
7.47-0.10 (-1.32%)
At close: 4:00 PM EDT
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close7.57
Bid6.13 x 200
Ask7.94 x 300
Day's Range7.45 - 7.69
52wk Range4.98 - 11.78
1y Target EstN/A
Market Cap1.06B
P/E Ratio (ttm)-5.31
Avg Vol (3m)2,132,825
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Five Cheap Healthcare Stocks Poised to Explode
    Insider Monkey15 days ago

    Five Cheap Healthcare Stocks Poised to Explode

    The healthcare sector has witnessed a significant correction in the last 15 months, with many prominent names in the industry losing a noteworthy chunk of their market capitalization in that time. While this decline has made investors cautious about the sector which was once the hottest out there, making new highs every day, it has also […]

  • 3 Biotechs With Potential Big-Time Upside
    Motley Fool27 days ago

    3 Biotechs With Potential Big-Time Upside

    These three high-risk/high-reward biotechs have drugs in late-stage trials and key catalysts just around the corner.

  • GlobeNewswirelast month

    Amicus Therapeutics to Present at LEERINK Roundtable Series: Rare Disease & Immuno-Oncology

    CRANBURY, N.J., Sept. 22, 2016-- Amicus Therapeutics, a global biotechnology company at the forefront of therapies for rare and orphan diseases, today announced that John F. Crowley, Chairman and Chief ...